{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T22:30:50Z","timestamp":1772836250604,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CPD"],"published-print":{"date-parts":[[2000,8,1]]},"DOI":"10.2174\/1381612003399581","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T01:10:31Z","timestamp":1111713031000},"page":"1211-1248","source":"Crossref","is-referenced-by-count":29,"title":["Dopamine Agonists in the Treatment of Parkinsons Disease-Past, Present and Future"],"prefix":"10.2174","volume":"6","author":[{"given":"S.","family":"Sit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/65499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T14:43:07Z","timestamp":1448030587000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1381-6128&volume=6&issue=12&spage=1211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8,1]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2000,8,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612003399581","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8,1]]}}}